CORRECTED: Mylan's Inequitable Conduct Claim Axed In Vytorin IP Suit
By Erin Marie Daly · May 19, 2011, 1:51 PM EDT
Schering Corp. on Tuesday won the dismissal of an inequitable conduct counterclaim by Mylan Pharmaceuticals Inc. in a ruling in Schering's lawsuit accusing the generic-drug maker of infringing its patents on...
To view the full article, register now.